Champions Oncology (FRA:2I3) Short Percentage of Float


FRA:2I3 Champions Oncology Inc FRA:2I3
61 GF Score
Price €4.98
GF Value €5.46
! 2 Warning Signs
View Full Analysis

What is Champions Oncology Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:2I3 vs SEER, RLYB, FBIO: Short Percentage of Float Comparison

For the Biotechnology subindustry, Champions Oncology's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Champions Oncology Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Champions Oncology's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Champions Oncology's Short Percentage of Float falls into.


FRA:2I3
61GF Score
Champions Oncology Inc FRA:2I3
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Champions Oncology (FRA:2I3) Overvalued in 2026?

Based on GuruFocus' analysis, Champions Oncology stock appears to be undervalued. The current stock price of €4.98 is trading 8.8% below its estimated GF Value™ of €5.46.

Key valuation signals for FRA:2I3:

  • Short Percentage of Float:
  • GF Value™: €5.46 vs. price of €4.98 (8.8% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the FRA:2I3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Champions Oncology Business Description

Other Exchanges CSBR:USA
Address One University Plaza, Suite 307, Hackensack, NJ, USA, 07601
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
61GF Score

Get the complete analysis for FRA:2I3

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.98
Price
€5.46
GF Value